Chemed 10-Q Details Q3 Beat, $60.6M RotoCo Deal and $236M Debt Load
CHE sits 46% above its 52-week low of $365.205 on elevated volume (2.1× avg).
Summary
Chemed's Q3 10-Q backs up the October 27 beat with full financials: revenue of $690.9M and diluted EPS of $5.45, plus disclosure that 2026 acquisitions and buybacks pushed long-term debt to $236.0M.
Key Events · Earnings and Guidance · CHE
-
Q3 Revenue Up 10.6% to $690.9M
Third-quarter service revenues and sales rose to $690.9M from $624.9M, with VITAS up 12.2% on a 9.4% increase in days of care and Roto-Rooter up 7.5%.
-
Diluted EPS $5.45; Adjusted $6.75
Net income was $71.6M, or $5.45 diluted, versus $4.46 a year ago; adjusted diluted EPS was $6.75 and adjusted EBITDA $133.8M (19.4% of revenue).
-
RotoCo Deal Closed for $60.6M
Roto-Rooter acquired RotoCo, LLC, its largest independent franchise, on September 16, 2026 for $60.6M; total 2026 acquisitions of $96.05M added $87.8M of goodwill.
-
Debt Rises to $236.0M on Buybacks
Long-term debt outstanding was $236.0M versus none at December 31, 2025, after $353.6M of nine-month buybacks and $96.1M of acquisitions; $166.7M remains undrawn on the $450M revolver and covenants were met.
Analysis · CHE · Industrial Applications And Services
The headline numbers were already out on October 27, so the print itself won't reprice the stock. What this 10-Q adds is the balance-sheet story: Chemed funded $96.1M of franchise acquisitions and $353.6M of buybacks this year, which flipped it from debt-free at December 31 to $236.0M drawn on its revolver and cut cash to $48.4M from $74.5M. VITAS drove the quarter — revenue up 12.2% on 9.4% more days of care and a much smaller Medicare Cap hit ($0.8M vs $6.1M) — while Roto-Rooter's operating income slipped to $34.9M from $38.6M on heavier advertising, fuel and acquisition costs. With $166.7M still available on the revolver and leverage comfortably inside the 3.50x covenant, the capital-return pace looks sustainable, but the margin mix has shifted toward the regulated hospice business.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CHE was trading at $534.88 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7B. The 52-week trading range was $365.21 to $562.24. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.